Complexities of Current Gout Therapy: Reducing Flares While Managing Risk
Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP
Professor of Clinical Sciences
Drake University College of Pharmacy & Health Sciences
Des Moines, Iowa
FACULTY DISCLOSURE STATEMENTS:
Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP, has no real or apparent conflicts of interest in relation to this program.
Susanne Batesko, RN, BSN, Michele Salernitano, the clinical reviewers, planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credits: 2.0 hours (0.20 ceu)
Type of Activity: Knowledge
This accredited activity has been designed for Pharmacists.
Exam processing and other inquiries and booklet orders to:
CE Customer Service: (800) 825-4696 or firstname.lastname@example.org
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
To provide pharmacists with the knowledge necessary to appropriately manage adult patients with methicillin-resistant Staphylococcus aureus (MRSA) infections.
After completing this activity, the participant should be able to:
- Review pathogenesis and epidemiology of gout;
- Discuss current clinical guidelines for the management of gout;
- Discuss the medications currently approved in the United States for the treatment of gout, including dosage forms, formulations, and administration; and
- Recognize the potential issues surrounding U.S. Food and Drug Administration approved and unapproved formulations of the medications used to treat gout.